Freely Filtered 051: Pip Tazo and Vanco: Nephrotoxin or Not so toxic

1

Introduction

00:00 • 3min

2

The Biomedical Community on Twitter

03:16 • 2min

3

Nephrology Podcast - Freely Filter

05:39 • 2min

4

Is Pip Taz Vanko Really Nephrotoxic?

07:18 • 2min

5

Is There a Pseudo-Naphrotoxicity?

09:08 • 2min

6

Is There a Synergistic Nephrotaxis?

10:49 • 2min

7

Is AKI Causing Toxicity or Is It the AKI?

12:59 • 2min

8

Is There a Risk of Creatinine Defined AKI?

15:04 • 2min

9

Sistadency and the Sepsis Cohort

16:41 • 2min

10

The Mesh Study of Sepsis in the ICU

19:03 • 4min

11

How Did You Determine AKI With Cystad in C?

22:37 • 2min

12

Cystatency in AKI

24:22 • 2min

13

Is Cystatency a Biomarker of Kidney Function?

26:18 • 2min

14

The Key Aspect Is Selection Bias

28:31 • 2min

15

Confounding by Indication - What's the Right Approach?

30:11 • 2min

16

What Are the Big Confoundings in This?

32:35 • 2min

17

AKI - What's Your Go-to Antibiotic?

34:40 • 2min

18

The Epidemiology of Sepsis

36:29 • 3min

19

Piptazo Versus Cephaline - What's the Key Finding?

39:58 • 2min

20

The Ratio of Systatin C to Creatinine in the Pitasal Arm

41:39 • 1min

21

AKI in the Piptaso Group Versus Sephapine Group

43:09 • 2min

22

Is Piptaso a Better Drug or Sephapine?

44:44 • 2min

23

Is There a Null Association Between Piptaso and Mortality?

46:33 • 2min

24

Cystatancy and Acute Kidney Injury

48:20 • 2min

25

Is Cystatancy Going to Be One of the New Labs?

49:51 • 3min

26

Do We Need to Use Van Copyptha?

52:24 • 2min

27

Is This Nephrotoxic or Pseudo-Dephrotoxicity?

54:37 • 2min

28

Is There a Time Frame for Nephrotoxicity?

56:14 • 2min

29

Is Creatinine a Good Biomarker?

58:04 • 2min

30

Chronic Kidney Disease - What's Next?

59:36 • 2min

31

Is This Going to Be the Next Venus Contrast to Be?

01:01:09 • 2min

32

RCTs Are the Pinnacle of Our Pledge Drive

01:02:52 • 2min

33

The Best Place to Go to Play Golf Is Bandon Dunes

01:04:25 • 3min